Dr King has experience in biotechnology research, project management and biotechnology startup management. He has helped move vaccines, and vaccine delivery systems into clinical trials. His scientific expertise includes immunology, vaccinology, gene delivery, electroporation, electrofusion for hybridomas, and antibody synthesis.

Dr. Gertz has a Ph.D. in Pathobiology from the Johns Hopkins University School of Medicine. He has been in the biotechnology field for over 10 years where he has led preclinical development and validation. His scientific expertise includes pathology, neurology, cell and stem cell culture, and recombinant protein engineering. Dr. Gertz is a partner and VP of Research at Synaptic Research, LLC and a co-founder and VP of Research at Synterica, Inc.

Dr. Deitz received his PhD in Molecular Biology from the University of Colorado Health Sciences Center (now Anschutz Medical Campus). He has 17 years of experience in the fields of viral immunology, vaccinology, drug discovery, and live animal research. He was principal investigator on a SBIR grant and is a co-inventor on multiple patents and patent applications. Dr. Deitz is co-founder and CSO of Syndecion and a co-founder of Synterica, Inc.

Dr. Oyler holds MD and PhD degrees in neuroscience. Dr. Oyler has been affiliated with several prestigious research and medical institutions, including the Scripps Research Institute, Pennsylvania State University, Johns Hopkins University, and the University of Maryland. Dr. Oyler is a recognized expert in the biochemistry of neural function, with particular emphasis on the effect of neurotoxins, especially the Botulinum Toxin.